{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:40:15Z","timestamp":1772811615879,"version":"3.50.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,10,1]]},"DOI":"10.1093\/ajhp\/55.19.1979","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T03:52:45Z","timestamp":1550893965000},"page":"1979-1986","source":"Crossref","is-referenced-by-count":17,"title":["Anagrelide, a selective thrombocytopenic agent"],"prefix":"10.1093","volume":"55","author":[{"given":"Maryann D.","family":"Oertel","sequence":"first","affiliation":[{"name":"Drug Information Services, Department of Pharmacy, University of North Carolina Hospitals, Chapel Hill."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/55\/19\/1979\/28403814\/ajhp1979.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,14]],"date-time":"2019-04-14T11:49:01Z","timestamp":1555242541000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/55\/19\/1979\/5157454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10,1]]},"references-count":0,"journal-issue":{"issue":"19","published-print":{"date-parts":[[1998,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/55.19.1979","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1998,10,1]]},"published":{"date-parts":[[1998,10,1]]}}}